Answers are grounded in this paper and cite their sources.
BACKGROUND: Acute kidney injury (AKI) is a common complication of sepsis and is associated with increased morbidity and mortality in critically ill patients. Combined assessment of serum pentraxin 3 (PTX3), uromodulin (UMOD), and circulating microRNAs (miRNAs) may improve understanding of the pathophysiology of septic AKI. METHODS: In this study, 81 critically ill adults with sepsis were stratified into AKI and non-AKI groups, and 90 healthy volunteers served as controls. Blood samples were collected on days 1 and 4 after the diagnosis of sepsis. PTX3 and UMOD concentrations were measured by ELISA, and miRNA expression was assessed by RT-qPCR. Seven miRNAs were validated, and their target genes associations were analyzed using TargetScanHuman8.0. RESULTS: PTX3 and UMOD distinguished healthy controls from septic patients, whereas only PTX3 differentiated patients with AKI from non-AKI. Baseline PTX3 and procalcitonin were independently associated with AKI on days 1 and 4. In AKI group, four analyzed miRNAs showed significant intercorrelations on day 1; however, these weakened by day 4 with changes in renal function and sepsis. Selected miRNAs were interpreted in the context of predicted target genes and pathways related to NF-κB signaling, renal cell apoptosis, and autophagy/mitophagy, rather than as direct causal regulators demonstrated in this study. CONCLUSIONS: PTX3, UMOD, and selected miRNAs provide complementary information on septic AKI and support a multifactorial concept of its pathophysiology.The study was registered at ClinicalTrials.gov (ID: NCT06498336) on May 2, 2024 to March 31, 2026.
No takes yet. Share an insight, caveat, or question.
Petejová et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: